文献速递产科

利多卡因贴剂用于肥胖产妇剖宫产后镇痛的随机对照试验

Lidocaine patches for postcesarean pain control in obese women: a pilot randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-11-26

该单盲预试验纳入61例肥胖剖宫产产妇,比较切口周围贴敷5%利多卡因贴剂与安慰剂贴剂对术后24小时阿片类药物累积用量的影响。结果显示两组吗啡毫克当量无显著差异,疼痛评分及满意度亦无统计学差异,提示该干预未能减少阿片类药物用量。

要点

  • 肥胖剖宫产产妇切口旁贴敷5%利多卡因贴剂未减少24小时阿片用量。
  • 利多卡因贴剂组与安慰剂组疼痛评分中位数无统计学差异。
  • 该预试验结果不支持开展更大规模试验验证此干预的镇痛获益。

核心结论

  • 在肥胖剖宫产产妇中,切口上方及侧方贴敷5%利多卡因贴剂未能降低术后24小时平均吗啡毫克当量总用量,也未改善中位疼痛评分。

研究设计与样本

  • 单盲随机对照预试验,于2019年2月至9月在社区三级转诊医院纳入61例肥胖剖宫产产妇,利多卡因组30例、安慰剂组31例。
  • 干预为术后在切口敷料上方及侧方贴敷5%利多卡因贴剂或安慰剂贴剂并保留12小时。
  • 主要结局为术后24小时内阿片类药物累积用量(以吗啡毫克当量计),样本量60例(每组30例)用于为未来正式试验提供依据。

主要发现

  • 利多卡因组24小时平均阿片用量为87.0吗啡毫克当量(标准差35.8),安慰剂组为83.9(标准差27.5),P=.702。
  • 利多卡因组与安慰剂组中位疼痛评分分别为3.0(四分位距2.1-4.9)和3.5(四分位距2.5-5.0),P=.217。
  • 首次阿片用药时间、阿片总次数、48小时及整个住院期间总吗啡毫克当量均无差异,两组患者满意度均高且无统计学差异。

临床怎么用

  • 对于肥胖剖宫产产妇,不建议常规使用切口周围5%利多卡因贴剂来减少术后阿片类药物用量或改善疼痛。

局限性

  • 本研究为预试验,样本量较小(61例),主要目的是为未来正式试验提供参数依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity increases the risk of opioid-related morbidity. Lidocaine patches have been shown to reduce postoperative pain after noncesarean surgeries. OBJECTIVE: This study aimed to determine whether the application of lidocaine patches around the cesarean incision in women with obesity reduces the total dose of opioids administered in the first 24 hours after cesarean delivery. STUDY DESIGN: This was a pilot single-blind randomized controlled trial of 61 women with obesity undergoing cesarean delivery at a community tertiary referral hospital staffed by academic physicians. After cesarean delivery, the allocated patches (either 5% lidocaine patches or placebo patches) were applied superior and lateral to the incision dressing and remained in place for 12 hours. The average cumulative opioid dose received within the first 24 hours after cesarean delivery was measured in morphine milligram equivalents. We also assessed pain and patient satisfaction. A sample size of 60 (30 per group) was determined to be adequate to inform a future appropriately powered randomized controlled trial. The primary outcome of morphine milligram equivalents was compared using the Student t test, and pain scores were compared using the Wilcoxon rank sum test. RESULTS: Of the 146 women screened between February 2019 and September 2019, 61 consented and were analyzed: 30 women were allocated to lidocaine patch and 31 were allocated to placebo (hydrocolloid patch). Women who were allocated to the lidocaine patch used an average of 87.0 (standard deviation, 35.8) morphine milligram equivalents of opioids in the first 24 hours compared with an average of 83.9 (standard deviation, 27.5) morphine milligram equivalents among women who were allocated to the placebo patch (P=.702). Women who were allocated to the lidocaine vs placebo patches reported median pain scores of 3.0 (interquartile range, 2.1-4.9) and 3.5 (interquartile range, 2.5-5.0), respectively (P=.217). The time to the first dose of opioids, total number of opioid doses, and total morphine milligram equivalents in 48 hours and for the entire hospital stay did not differ. Patient satisfaction with both patches was high and not statistically different. CONCLUSION: This pilot suggests that 5% lidocaine patches applied superior and lateral to the cesarean incision are not effective at reducing the average total dose of morphine milligram equivalents administered in the first 24 hours after cesarean delivery among women with obesity, and they did not seem to improve median pain scores. An appropriately powered randomized trial would not be expected to demonstrate reduction in opioid use or pain.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Antony KM, Adams JH, Jacques L, et al. Lidocaine patches for postcesarean pain control in obese women: a pilot randomized controlled trial. Am J Obstet Gynecol MFM. 2020. PMID: 33451596. doi:10.1016/j.ajogmf.2020.100281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。